Champions Oncology Inc Shares Close in on 52-Week Low - Market Mover
The shares closed 1.7% above its 52-week low of $7.75, with trading volume higher than its 30 day average
Jan 08, 2022 by Kwhen Finance Editors
Champions Oncology Inc (CSBR) shares closed today at 1.7% above its 52 week low of $7.75, giving the company a market cap of $106M. The stock is currently down 5.7% year-to-date, down 29.3% over the past 12 months, and up 144.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.7%.
Trading Activity
- Trading volume this week was 61.7% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
- The stock closed at 3.6% lower than its 5-day moving average, 2.5% lower than its 20-day moving average, and 16.3% lower than its 90-day moving average.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Champions Oncology Inc | -1.1 | -5.7 | -29.3 | -44.8 | 4.5 |
| Dow Jones Industrial Average | -0.0 | -0.3 | 19.6 | -2.0 | 23.2 |
| S&P 500 Index | -0.4 | -1.5 | 26.9 | -2.5 | 28.8 |
| Health Care | -0.7 | -5.2 | 13.5 | -5.5 | 21.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -41.8%
- The company's stock price performance over the past 12 months lags the peer average by -306.7%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Champions Oncology Inc | CSBR | 0 | -5.7 | -29.3 | -44.8 | 4.5 |
| Peer Avg | N/A | 185.1 | -9.9 | 14.2 | -39.4 | 38.8 |
| Charles River Laboratories International Inc. | CRL | 42.5 | -11.4 | 31.1 | -27.5 | 33.7 |
| Exelixis Inc | EXEL | 35.2 | 0.1 | -16.3 | -28.4 | 19.1 |
| Celldex Therapeutics Inc. | CLDX | -23.6 | -5.4 | 109.0 | -37.2 | 133.8 |
| Heska Corp. (Restricted Voting) | HSKA | 871.2 | -16.6 | -4.0 | -44.7 | 2.7 |
| Nanostring Technologies Inc | NSTG | 0 | -16.0 | -48.8 | -59.0 | 4.9 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: